# Somira Health reviews (2026): GLP-1 telehealth sellers | This GLP

The price is stated as locked while the dose rises, on both plan lengths.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/somira-health
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Locked as you titrate

# Somira Health review

The price is stated as locked while the dose rises, on both plan lengths.

## The verdict

Somira Health publishes $139.99 a month for compounded semaglutide and $159.99 for tirzepatide. Each renews at the same figure every month. The price is stated as locked during titration.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $139.99/mo

Prescription

Required

Compounded

Yes — not FDA-approved

Somira Health sells both molecules by injection. Two billing options exist. The quarterly plan is billed as a single total.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription precedes shipping. The pages state plans and totals. The clinician is not described.
    
    The titration guarantee is the claim to hold them to. It applies to both plan lengths and it is stated rather than implied.
    
2.  ## What happens when the dose goes up?
    
    Price locked as you titrate is the seller's own wording. That answers the dose question directly. Nothing describes clinical support at a step.
    
3.  ## What the price includes
    
    Six months month to month is $839.94 on semaglutide and $959.94 on tirzepatide. A quarterly plan bills in one charge at a lower monthly equivalent. The configurator shows its total before checkout.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: Price stated as locked during titration
-   Strength: Quarterly totals published, not just rates
-   Strength: The pharmacy is named on the plan card
-   Limitation: The quarterly plan bills in one charge
-   Limitation: No milligram dose published
-   Limitation: No state coverage list is recorded

## What the evidence says about this kind of treatment

The assessment above is about Somira Health. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who wants the rate pinned across an escalation.

Wrong for

A reader who needs a monthly charge rather than a quarterly one.

## The evidence behind what Somira Health prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Somira Health compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Sunlight | Readers who want a rate guaranteed against increases and will count the fills |  |
| SurpassMD | Readers who will ask what their own approved figure is |  |
| TeleCareSpot | Readers confident of approval who want a flat all-in rate |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [WeightRx](https://thisglp.com/reviews/weightrx) [WeightWatchers Clinic](https://thisglp.com/reviews/weight-watchers) [Welling Health](https://thisglp.com/reviews/welling-health) [Wellspring Longevity Clinic](https://thisglp.com/reviews/wellspring-longevity-clinic) [WePeptideRx](https://thisglp.com/reviews/wepeptiderx) [Wholesome Clinic](https://thisglp.com/reviews/wholesome-clinic)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Does the price rise with the dose?

No. The seller states the price is locked as you titrate.

What does the quarterly plan cost?

It bills once a quarter, below the monthly rate. The configurator shows the total before checkout.

What does tirzepatide cost?

$159.99 a month, renewing at the same figure each month.

Is Somira Health expensive compared with other GLP-1 telehealth sellers?

Somira Health publishes a starting figure of $139.99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Somira Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
